RxSight (RXST) Interest Expenses (2020 - 2026)

RxSight's Interest Expenses history runs 7 years deep, the most recent figure standing at $15.0 million for Q1 2026.

• Quarterly Interest Expenses fell 70.4% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (down 70.4% YoY) and the FY2025 annual result came in at $3.7 million, down 96.98% from the prior year.
• Interest Expenses was $15.0 million for Q1 2026 at RxSight, up from $2.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $257.2 million in Q2 2024 and bottomed at -$1.1 million in Q4 2023.
• A 5-year average of $61.4 million and a median of $16.7 million in 2025 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses soared 2249.57% — and 2023, when it slumped 174.98%.
• RxSight's Interest Expenses stood at $1.5 million in 2022, then plunged by 174.98% to -$1.1 million in 2023, then jumped by 147.89% to $521000.0 in 2024, then surged by 401.54% to $2.6 million in 2025, then soared by 475.51% to $15.0 million in 2026.
• Business Quant data shows RXST's Interest Expenses at $15.0 million in Q1 2026, $2.6 million in Q4 2025, and $16.7 million in Q3 2025.